Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Treatment of Dyspnoea in Advanced Cancer Patients: ESMO Clinical Practice Guidelines

Published in 2015 – Ann Oncol (2015) 26 (suppl 5): v169-v173.
Authors:M. Kloke and N. Cherny

Dyspnoea is described as difficult or laboured breathing and is a frequent symptom in advanced cancer patients, with the highest prevalence in lung cancer. Dyspnoea has been demonstrated to be one of the most distressing cancer symptoms and requires a multidisciplinary approach in patient management and care. The new ESMO Clinical Practice Guidelines on the treatment of dyspnoea in advanced cancer patients focus on dyspnoea management strategies including treating reversible causes, non-pharmacological interventions and pharmacological treatment such as opioids, benzodiazepines and other drugs.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings